Acute neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia

Neuroscience

Volumn 169, Issue 1, 2010, Pages 395-401

  Antonucci, F ^a   Cerri, C ^b   Vetencourt, J F Maya ^b   Caleo, M ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

Author keywords

Glutamate release; Hippocampus; SNAP 25; Stroke; Synaptic transmission

Indexed keywords

BOTULINUM TOXIN E; ENDOTHELIN 1; GLUTAMIC ACID; SNARE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; DISEASE MODEL; ENCEPHALE ISOLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IN VIVO STUDY; INHIBITION KINETICS; MICRODIALYSIS; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

ANIMALS; BOTULINUM TOXINS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG EVALUATION, PRECLINICAL; ENDOTHELIN-1; FEMALE; GLUTAMIC ACID; MICRODIALYSIS; NEUROPROTECTIVE AGENTS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TIME FACTORS;

EID: 77953807140     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.04.059     Document Type: Article

References (44)

1. Antonucci F., Rossi C., Gianfranceschi L., Rossetto O., Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 2008, 28:3689-3696.
2. Antonucci F., Di Garbo A., Novelli E., Manno I., Sartucci F., Bozzi Y., Caleo M. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Exp Neurol 2008, 210:388-401.
3. Arundine M., Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004, 61:657-668.
4. Ashton A.C., Dolly J.O. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J Neurochem 1988, 50:1808-1816.
5. Bartus R.T., Dean R.L., Mennerick S., Eveleth D., Lynch G. Temporal ordering of pathogenic events following transient global ischemia. Brain Res 1998, 790:1-13.
6. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984, 43:1369-1374.
7. Berger C., Schabitz W.R., Georgiadis D., Steiner T., Aschoff A., Schwab S. Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study. Stroke 2002, 33:519-524.
8. Biernaskie J., Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J Neurosci 2001, 21:5272-5280.
9. Bogaert L., Scheller D., Moonen J., Sarre S., Smolders I., Ebinger G., Michotte Y. Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model for focal cerebral ischemia. Brain Res 2000, 887:266-275.
10. Bozzi Y., Costantin L., Antonucci F., Caleo M. Action of botulinum neurotoxins in the central nervous system: antiepileptic effects. Neurotox Res 2006, 9:197-203.
11. Calabresi P., Cupini L.M., Centonze D., Pisani F., Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 2003, 53:693-702.
12. Caleo M., Restani L., Gianfranceschi L., Costantin L., Rossi C., Rossetto O., Montecucco C., Maffei L. Transient synaptic silencing of developing striate cortex has persistent effects on visual function and plasticity. J Neurosci 2007, 27:4530-4540.
13. Colbourne F., Li H., Buchan A.M., Clemens J.A. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke 1999, 30:662-668.
14. Costantin L., Bozzi Y., Richichi C., Viegi A., Antonucci F., Funicello M., Gobbi M., Mennini T., Rossetto O., Montecucco C., Maffei L., Vezzani A., Caleo M. Antiepileptic effects of botulinum neurotoxin E. J Neurosci 2005, 25:1943-1951.
15. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
16. Fuxe K., Bjelke B., Andbjer B., Grahn H., Rimondini R., Agnati L.F. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport 1997, 8:2623-2629.
17. Fuxe K., Kurosawa N., Cintra A., Hallstrom A., Goiny M., Rosen L., Agnati L.F., Ungerstedt U. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res 1992, 88:131-139.
18. Gilmour G., Iversen S.D., O'Neill M.F., Bannerman D.M. The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behav Brain Res 2004, 150:171-183.
19. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008, 55:363-389.
20. Hughes P.M., Anthony D.C., Ruddin M., Botham M.S., Rankine E.L., Sablone M., Baumann D., Mir A.K., Perry V.H. Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol 2003, 62:1276-1286.
21. Larsson E., Lindvall O., Kokaia Z. Stereological assessment of vulnerability of immunocytochemically identified striatal and hippocampal neurons after global cerebral ischemia in rats. Brain Res 2001, 913:117-132.
22. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature 1999, 399:A7-A14.
23. Liou A.K., Clark R.S., Henshall D.C., Yin X.M., Chen J. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 2003, 69:103-142.
24. Lustig H.S., Chan J., Greenberg D.A. Comparative neurotoxic potential of glutamate, endothelins, and platelet-activating factor in cerebral cortical cultures. Neurosci Lett 1992, 139:15-18.
25. Mateffyova A., Otahal J., Tsenov G., Mares P., Kubova H. Intrahippocampal injection of endothelin-1 in immature rats results in neuronal death, development of epilepsy and behavioral abnormalities later in life. Eur J Neurosci 2006, 24:351-360.
26. Maya Vetencourt J.F., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O.F., Castren E., Maffei L. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320:385-388.
27. Montecucco C., Molgo J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol 2005, 5:274-279.
28. Monyer H., Giffard R.G., Hartley D.M., Dugan L.L., Goldberg M.P., Choi D.W. Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin. Neuron 1992, 8:967-973.
29. Nikolov R., Rami A., Krieglstein J. Endothelin-1 exacerbates focal cerebral ischemia without exerting neurotoxic action in vitro. Eur J Pharmacol 1993, 248:205-208.
30. O'Neill M.J., Bogaert L., Hicks C.A., Bond A., Ward M.A., Ebinger G., Ornstein P.L., Michotte Y., Lodge D. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia. Neuropharmacology 2000, 39:1575-1588.
31. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994, 46:325-415.
32. Schiavo G., Montecucco C. Tetanus and botulism neurotoxins: isolation and assay. Methods Enzymol 1995, 248:643-652.
33. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000, 80:717-766.
34. Sharkey J., Butcher S.P. Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J Neurosci Methods 1995, 60:125-131.
35. Sharkey J., Ritchie I.M., Kelly P.A. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1993, 13:865-871.
36. Shuaib A., Hussain M.S. The past and future of neuroprotection in cerebral ischaemic stroke. Eur Neurol 2008, 59:4-14.
37. Ueki A., Rosen L., Andbjer B., Agnati L.F., Hallstrom A., Goiny M., Tanganelli S., Ungerstedt U., Fuxe K. Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat. Exp Brain Res 1993, 96:89-99.
38. Valtysson J., Hillered L., Andine P., Hagberg H., Persson L. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation. Acta Neurochir (Wien) 1994, 129:58-63.
39. Van Hemelrijck A., Vermijlen D., Hachimi-Idrissi S., Sarre S., Ebinger G., Michotte Y. Effect of resuscitative mild hypothermia on glutamate and dopamine release, apoptosis and ischaemic brain damage in the endothelin-1 rat model for focal cerebral ischaemia. J Neurochem 2003, 87:66-75.
40. Verderio C., Grumelli C., Raiteri L., Coco S., Paluzzi S., Caccin P., Rossetto O., Bonanno G., Montecucco C., Matteoli M. Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 2007, 8:142-153.
41. Verderio C., Pozzi D., Pravettoni E., Inverardi F., Schenk U., Coco S., Proux-Gillardeaux V., Galli T., Rossetto O., Frassoni C., Matteoli M. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 2004, 41:599-610.
42. Vidwans A.S., Hewett S.J. Enhanced release of synaptic glutamate underlies the potentiation of oxygen-glucose deprivation-induced neuronal injury after induction of NOS-2. Exp Neurol 2004, 190:91-101.
43. Windle V., Szymanska A., Granter-Button S., White C., Buist R., Peeling J., Corbett D. An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 2006, 201:324-334.
44. Zhang Q.G., Raz L., Wang R., Han D., De Sevilla L., Yang F., Vadlamudi R.K., Brann D.W. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci 2009, 29:13823-13836.